Skip to main content
. 2016 Jan 6;34:509–520. doi: 10.1007/s40273-015-0366-8

Fig. 2.

Fig. 2

Incremental costs versus QALYs for oral PAH therapies versus supportive care in PAH functional class III. QALYs quality-adjusted life-years, PAH pulmonary arterial hypertension